Vir Biotechnology VIR
NASDAQ VIR
$11.44 -0.01 (-0.09%)
As of: Sep 4, 2026 · 3:19 PM EDT

Vir Biotechnology (VIR) Net Equity Issued and Repurchased (2018 - 2026)

Vir Biotechnology (VIR) posted Net Equity Issued and Repurchased of $162.3 million for Q1 2026, up 290.52% sequentially from -$85.2 million in Q4 2021.

Analysis

Vir Biotechnology (VIR) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

Vir Biotechnology has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $162.3 million in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $162.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.1 million (up 190.52% YoY) and the FY2020 annual result came in at $323.2 million, up 1.85% from the prior year.
  • Net Equity Issued and Repurchased advanced to $162.3 million in Q1 2026 per VIR's latest filing, from -$85.2 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $162.3 million in Q1 2026 and troughed at $162.3 million in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - 141.90 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Vir Biotechnology 1.92 Bn 1.92 Bn 238.95 Mn -144,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -144,000.00
Mar 31, 2026 162.35 Mn
Dec 31, 2021 -85.21 Mn
Mar 31, 2021 85.21 Mn
Sep 30, 2020 116.52 Mn
Jun 30, 2019 -7,000.00
Mar 31, 2019 317.34 Mn
Dec 31, 2018 39,000.00